AIMZ Investment Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.39M | Buy |
17,735
+5
| +0% | +$403 | 0.38% | 70 |
|
|
2026
Q1 | $1.54M | Buy |
17,730
+4
| +0% | +$383 | 0.47% | 63 |
|
|
2025
Q4 | $1.7M | Buy |
17,726
+4
| +0% | +$389 | 0.49% | 61 |
|
|
2025
Q3 | $1.69M | Buy |
17,722
+5
| +0% | +$460 | 0.53% | 60 |
|
|
2025
Q2 | $1.54M | Sell |
17,717
-30
| -0.2% | -$2.54K | 0.52% | 63 |
|
|
2025
Q1 | $1.59M | Sell |
17,747
-195
| -1% | -$17.4K | 0.56% | 59 |
|
|
2024
Q4 | $1.43M | Sell |
17,942
-170
| -0.9% | -$14.7K | 0.5% | 60 |
|
|
2024
Q3 | $1.63M | Sell |
18,112
-145
| -0.8% | -$12.2K | 0.56% | 54 |
|
|
2024
Q2 | $1.44M | Sell |
18,257
-71
| -0.4% | -$5.82K | 0.52% | 58 |
|
|
2024
Q1 | $1.6M | Buy |
18,328
+5
| +0% | +$427 | 0.6% | 55 |
|
|
2023
Q4 | $1.51M | Buy |
18,323
+5
| +0% | +$381 | 0.61% | 54 |
|
|
2023
Q3 | $1.44M | Sell |
18,318
-96
| -0.5% | -$8.04K | 0.64% | 52 |
|
|
2023
Q2 | $1.62M | Buy |
18,414
+4
| +0% | +$344 | 0.7% | 49 |
|
|
2023
Q1 | $1.48M | Sell |
18,410
-95
| -0.5% | -$7.74K | 0.66% | 49 |
|
|
2022
Q4 | $1.44M | Sell |
18,505
-146
| -0.8% | -$11.8K | 0.68% | 51 |
|
|
2022
Q3 | $1.51M | Buy |
18,651
+4
| +0% | +$359 | 0.76% | 46 |
|
|
2022
Q2 | $1.67M | Buy |
18,647
+3
| +0% | +$304 | 0.8% | 44 |
|
|
2022
Q1 | $2.07M | Sell |
18,644
-730
| -4% | -$77.1K | 0.85% | 43 |
|
|
2021
Q4 | $2M | Buy |
19,374
+703
| +4% | +$81.4K | 0.78% | 44 |
|
|
2021
Q3 | $2.34M | Sell |
18,671
-128
| -0.7% | -$16.6K | 1.06% | 34 |
|
|
2021
Q2 | $2.33M | Sell |
18,799
-48
| -0.3% | -$6.03K | 1.05% | 35 |
|
|
2021
Q1 | $2.23M | Buy |
18,847
+3
| +0% | +$352 | 1.09% | 35 |
|
|
2020
Q4 | $2.21M | Buy |
18,844
+3
| +0% | +$330 | 1.16% | 35 |
|
|
2020
Q3 | $1.96M | Buy |
18,841
+2
| +0% | +$201 | 1.17% | 34 |
|
|
2020
Q2 | $1.73M | Sell |
18,839
-47
| -0.2% | -$4.51K | 1.12% | 36 |
|
|
2020
Q1 | $1.7M | Buy |
18,886
+2
| +0% | +$213 | 1.32% | 31 |
|
|
2019
Q4 | $2.14M | Buy |
18,884
+3
| +0% | +$329 | 1.39% | 29 |
|
|
2019
Q3 | $2.05M | Sell |
18,881
-98
| -0.5% | -$10.2K | 1.41% | 28 |
|
|
2019
Q2 | $1.85M | Sell |
18,979
-97
| -0.5% | -$8.86K | 1.27% | 28 |
|
|
2019
Q1 | $1.74M | Sell |
19,076
-47
| -0.2% | -$4.21K | 1.19% | 32 |
|
|
2018
Q4 | $1.74M | Buy |
19,123
+2
| +0% | +$187 | 1.34% | 32 |
|
|
2018
Q3 | $1.88M | Buy |
19,121
+3
| +0% | +$277 | 1.21% | 31 |
|
|
2018
Q2 | $1.64M | Sell |
19,118
-197
| -1% | -$16.5K | 1.16% | 32 |
|
|
2018
Q1 | $1.55M | Sell |
19,315
-198
| -1% | -$16.3K | 1.12% | 34 |
|
|
2017
Q4 | $1.58M | Buy |
19,513
+3
| +0% | +$240 | 1.18% | 32 |
|
|
2017
Q3 | $1.52M | Buy |
19,510
+2
| +0% | +$166 | 1.24% | 33 |
|
|
2017
Q2 | $1.73M | Sell |
19,508
-647
| -3% | -$54.6K | 1.46% | 22 |
|
|
2017
Q1 | $1.62M | Buy |
20,155
+2
| +0% | +$156 | 1.37% | 22 |
|
|
2016
Q4 | $1.44M | Buy |
20,153
+23
| +0.1% | +$1.81K | 1.28% | 28 |
|
|
2016
Q3 | $1.74M | Sell |
20,130
-648
| -3% | -$56.5K | 1.56% | 24 |
|
|
2016
Q2 | $1.8M | Sell |
20,778
-22,613
| -52% | -$1.83M | 1.65% | 22 |
|
|
2016
Q1 | $3.32M | Buy |
43,391
+21,443
| +98% | +$1.62M | 1.46% | 22 |
|
|
2015
Q4 | $1.69M | Sell |
21,948
-197
| -0.9% | -$14.8K | 1.54% | 22 |
|
|
2015
Q3 | $1.48M | Sell |
22,145
-197
| -0.9% | -$14.5K | 1.36% | 25 |
|
|
2015
Q2 | $1.66M | Buy |
22,342
+52
| +0.2% | +$3.97K | 1.44% | 23 |
|
|
2015
Q1 | $1.74M | Buy |
+22,290
| New | +$1.69M | 1.49% | 22 |
|
Other funds holding MDT
AIMZ Investment Advisors's MDT Position: Q2 2026 in Review
AIMZ Investment Advisors increased its Medtronic (MDT) stake by 0.03% in Q2 2026, buying an estimated $403 and bringing the position to 17,735 shares worth $1.39M. The position accounts for 0.38% of the portfolio, ranked #70.
AIMZ Investment Advisors first reported a position in MDT in Q1 2015 and has held it in 46 quarters since. The position peaked at $3.32M in Q1 2016. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- AIMZ Investment Advisors held 17,735 shares of Medtronic worth $1.39M as of Q2 2026.
- AIMZ Investment Advisors bought 5 Medtronic shares in Q2 2026, an estimated $403.
- Medtronic made up 0.38% of AIMZ Investment Advisors's portfolio in Q2 2026, its #70 holding.
- AIMZ Investment Advisors first reported a position in Medtronic in Q1 2015 and has held it in 46 quarters since.
- AIMZ Investment Advisors's Medtronic position peaked at $3.32M in Q1 2016.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on AIMZ Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.